Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma

Brain Pathology

Volumn 22, Issue 5, 2012, Pages 670-676

  Nagaishi, Masaya ^a   Paulus, Werner ^b   Brokinkel, Benjamin ^b   Vital, Anne ^c   Tanaka, Yuko ^d   Nakazato, Yoichi ^d   Giangaspero, Felice ^e,f   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UMR 5287   (France)

^d GUNMA UNIVERSITY   (Japan)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f IRCCS NEUROMED   (Italy)

Author keywords

epithelial to mesenchymal transition; gliosarcoma; MMP; Slug; Twist

Indexed keywords

GELATINASE A; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM TUMOR; FEMALE; GENE EXPRESSION; GLIOMA; GLIOSARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MESENCHYME CELL; PROTEIN EXPRESSION; STAINING;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CELL DIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSARCOMA; GLIOSIS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR;

EID: 84865473036     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00571.x     Document Type: Article

References (43)

1. Beaumont TL, Kupsky WJ, Barger GR, Sloan AE, (2007) Gliosarcoma with multiple extracranial metastases: case report and review of the literature. J Neurooncol 83: 39-46. (Pubitemid 46647163)
2. Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME, (1995) Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 54: 651-656.
3. Egeblad M, Werb Z, (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174. (Pubitemid 37328786)
4. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, et al, (2005) Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103: 1631-1643. (Pubitemid 40490024)
5. Gordon KJ, Kirkbride KC, How T, Blobe GC, (2009) Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis 30: 238-248.
6. Grunert S, Jechlinger M, Beug H, (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4: 657-665. (Pubitemid 36934968)
7. Hasselblatt M, Mertsch S, Koos B, Riesmeier B, Stegemann H, Jeibmann A, et al, (2009) TWIST-1 is overexpressed in neoplastic choroid plexus epithelial cells and promotes proliferation and invasion. Cancer Res 69: 2219-2223.
8. Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ, (2009) Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 64: 1082-1089.
9. Ishii K, Shimoda M, Sugiura T, Seki K, Takahashi M, Abe M, et al, (2011) Involvement of epithelial-mesenchymal transition in adenoid cystic carcinoma metastasis. Int J Oncol 38: 921-931.
10. Kalluri R, Neilson EG, (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784. (Pubitemid 38063698)
11. Kang Y, Massague J, (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118: 277-279. (Pubitemid 39061108)
12. Li L, Cserjesi P, Olson EN, (1995) Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol 172: 280-292.
13. Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT, (2011) Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102: 815-827.
14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, (eds) (2007) WHO Classification of Tumours of the Central Nervous System. IARC: Lyon.
15. Lun M, Lok E, Gautam S, Wu E, Wong ET, (2011) The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol 105: 261-273.
16. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al, (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715. (Pubitemid 351636299)
17. Martin TA, Goyal A, Watkins G, Jiang WG, (2005) Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 12: 488-496. (Pubitemid 40884264)
18. Mikami S, Katsube KI, Oya M, Ishida M, Kosaka T, Mizuno R, et al, (2011) Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis. Lab Invest 91: 1443-1458.
19. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, Khorasani L, et al, (2010) TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer 9: 194.
20. Nieto MA, Sargent MG, Wilkinson DG, Cooke J, (1994) Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264: 835-839. (Pubitemid 24193449)
21. Ojeda VJ, Sterrett GF, (1984) Cerebral gliosarcoma, pulmonary adenoid-cystic carcinoma, and pulmonary metastatic gliosarcoma: report of an untreated case. Pathology 16: 217-221. (Pubitemid 14130884)
22. Pasquier B, Pasquier D, Golet AN, Panh MH, Couderc P, (1980) Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of the literature. Cancer 45: 112-125. (Pubitemid 10214965)
23. Peinado H, Portillo F, Cano A, (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365-375. (Pubitemid 39360388)
24. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al, (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173. (Pubitemid 43357943)
25. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
26. Qiao B, Johnson NW, Gao J, (2010) Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. Int J Oncol 37: 663-668.
27. Radisky ES, Radisky DC, (2010) Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15: 201-212.
28. Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H, (2000) Genetic profile of gliosarcomas. Am J Pathol 156: 425-432. (Pubitemid 30643797)
29. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, et al, (2002) Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161: 1881-1891. (Pubitemid 35265545)
30. Smith DR, Hardman JM, Earle KM, (1969) Contiguous glioblastoma multiforme and fibrosarcoma with extracranial metastasis. Cancer 24: 270-276.
31. Smith DR, Hardman JM, Earle KM, (1969) Metastasizing neuroectodermal tumors of the central nervous system. J Neurosurg 31: 50-58.
32. Tan TK, Zheng G, Hsu TT, Wang Y, Lee VW, Tian X, et al, (2010) Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 176: 1256-1270.
33. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
34. Ullmann U, Gilles C, De RM, Van V, Sermon K, Liebaers I, (2008) GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol Hum Reprod 14: 169-179. (Pubitemid 351404890)
35. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al, (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
36. Wallerand H, Cai Y, Wainberg ZA, Garraway I, Lascombe I, Nicolle G, et al, (2010) Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Urol Oncol 28: 180-188.
37. Yang HW, Menon LG, Black PM, Carroll RS, Johnson MD, (2010) SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer 10: 301.
38. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al, (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939. (Pubitemid 38798858)
39. Yoshida J, Horiuchi A, Kikuchi N, Hayashi A, Osada R, Ohira S, et al, (2009) Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med Mol Morphol 42: 82-91.
40. Yu Q, Zhang K, Wang X, Liu X, Zhang Z, (2010) Expression of transcription factors snail, slug, and twist in human bladder carcinoma. J Exp Clin Cancer Res 29: 119.
41. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
42. Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, Chen Z, et al, (2011) EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene 30: 4941-4952.
43. Zuniga A, Quillet R, Perrin-Schmitt F, Zeller R, (2002) Mouse Twist is required for fibroblast growth factor-mediated epithelial-mesenchymal signalling and cell survival during limb morphogenesis. Mech Dev 114: 51-59. (Pubitemid 34462952)